Pendal Group’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Pendal Group’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,532	Closed	-$309K	–	644
2021 Q3	$309K	Buy	+3,532	New	+$320K	﹤0.01%	490
2019 Q4	–	Sell	-39,687	Closed	-$2.11M	–	507
2019 Q3	$2.11M	Sell	39,687 -2,774	-7%	-$142K	0.03%	204
2019 Q2	$2.17M	Buy	42,461 +2,207	+5%	+$103K	0.03%	202
2019 Q1	$2.08M	Hold	40,254	–	–	0.03%	209
2018 Q4	$1.58M	Sell	40,254 -323	-0.8%	-$15K	0.03%	220
2018 Q3	$2.09M	Hold	40,577	–	–	0.03%	204
2018 Q2	$1.9M	Buy	40,577 +1,848	+5%	+$76.5K	0.02%	235
2018 Q1	$1.37M	Buy	38,729 +14,001	+57%	+$548K	0.02%	283
2017 Q4	$1.08M	Buy	+24,728	New	+$1.16M	0.01%	289

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Pendal Group's SYNH Position: Q4 2021 in Review

Pendal Group sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2021, closing a stake of 3,532 shares — an estimated $309K sold.

Pendal Group first reported a position in SYNH in Q4 2017 and held it in 9 quarters. The position peaked at $2.17M in Q2 2019. 378 funds tracked by Wall St. Rank hold SYNH as of Q4 2021.

Pendal Group reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2021 after selling out during the quarter.
Pendal Group sold 3,532 Syneos Health, Inc. Class A Common Stock shares in Q4 2021, an estimated $309K.
Pendal Group first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2017 and held it in 9 quarters.
Pendal Group's Syneos Health, Inc. Class A Common Stock position peaked at $2.17M in Q2 2019.
378 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2021.

Based on Pendal Group's 13F filing for Q4 2021, filed 18 Jan 2022.